Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

Conditions:   Head and Neck Squamous Cell Carcinoma;   Colorectal Cancer;   Non Small Cell Lung Cancer;   Epidermal Growth Factor Receptor Inhibitor
Interventions:   Other: Cicaplast Balm B5;   Other: Dexeryl
Sponsor:   Centre Leon Berard
Not yet recruiting

http://ift.tt/2s8LIEN